这是一篇来自已证抗体库的有关小鼠 白细胞介素-6 (Il6) 的综述,是根据83篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合白细胞介素-6 抗体。
白细胞介素-6 同义词: Il-6

艾博抗(上海)贸易有限公司
小鼠 单克隆
  • 免疫印迹; 小鼠; 0.4 ug/ml; 图 7f
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫印迹在小鼠样本上浓度为0.4 ug/ml (图 7f). Aging (Albany NY) (2020) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 1:500; 图 6c
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6c). Aging (Albany NY) (2020) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 图 3b
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫印迹在大鼠样本上 (图 3b). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2b
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2b). Exp Dermatol (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5a
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Biosci Rep (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 1:1000; 图 3b
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3b). BMC Biotechnol (2019) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3d
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3d). Br J Pharmacol (2018) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 图 6a
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6a). J Cell Biochem (2018) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 图 1f
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化在人类样本上 (图 1f). Int J Mol Sci (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 5h
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5h). PLoS ONE (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4a
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1.1 ug/ml; 图 7
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样本上浓度为1.1 ug/ml (图 7). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在人类样本上 (图 1). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 1:100; 图 3
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化在大鼠样本上浓度为1:100 (图 3) 和 被用于免疫印迹在大鼠样本上 (图 4). BMC Cancer (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 (图 1). Autophagy (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 (图 1). Autophagy (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 大鼠; 图 4
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化-冰冻切片在大鼠样本上 (图 4). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; pigs ; 1:1000; 图 4
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在pigs 样本上浓度为1:1000 (图 4). Am J Physiol Regul Integr Comp Physiol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1a
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, AB6672)被用于被用于免疫印迹在小鼠样本上 (图 1a). Biol Sex Differ (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:3000; 图 5
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:3000 (图 5). Oncoimmunology (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 6
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫印迹在小鼠样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5
  • 免疫印迹; 人类; 1:1000; 图 3
艾博抗(上海)贸易有限公司白细胞介素-6抗体(abcam, ab6672)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 6
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样本上 (图 6). Mol Cancer (2016) ncbi
domestic rabbit 多克隆
  • 抑制或激活实验; 人类; 图 6
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于抑制或激活实验在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 酶联免疫吸附测定; 人类; 表 s4
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于酶联免疫吸附测定在人类样本上 (表 s4). ACS Nano (2016) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 图 1
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化在人类样本上 (图 1). PLoS ONE (2015) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 5f
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 5f). Oncogene (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化在人类样本上. Support Care Cancer (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; domestic rabbit; 0.5 ug/ml; 图 14
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为0.5 ug/ml (图 14). PLoS ONE (2015) ncbi
小鼠 单克隆
  • 酶联免疫吸附测定; 人类
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, Ab9324)被用于被用于酶联免疫吸附测定在人类样本上. Analyst (2015) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab9324)被用于被用于免疫印迹在大鼠样本上 (图 4). Am J Obstet Gynecol (2015) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1.0 ug/ml
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1.0 ug/ml. Mol Carcinog (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 图 2
艾博抗(上海)贸易有限公司白细胞介素-6抗体(Abcam, Ab9324)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). Gynecol Oncol (2015) ncbi
赛默飞世尔
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 人类; 1:100; 图 s12a
赛默飞世尔白细胞介素-6抗体(eBioscience, MPS-20F3)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s12a). Nat Commun (2018) ncbi
大鼠 单克隆(6B4 IGH 54)
  • 抑制或激活实验; 小鼠; 图 5b
赛默飞世尔白细胞介素-6抗体(eBioscience, BMS178)被用于被用于抑制或激活实验在小鼠样本上 (图 5b). J Immunol (2016) ncbi
大鼠 单克隆(MP5-32C11)
  • 酶联免疫吸附测定; 小鼠; 图 5c
赛默飞世尔白细胞介素-6抗体(eBioscience, 13-7062)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5c). Cell Death Differ (2016) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5c
赛默飞世尔白细胞介素-6抗体(eBioscience, 14-7061)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5c). Cell Death Differ (2016) ncbi
大鼠 单克隆(6B4 IGH 54)
  • 抑制或激活实验; 小鼠; 18 ug/ml; 图 7
赛默飞世尔白细胞介素-6抗体(eBioscience, BMS178)被用于被用于抑制或激活实验在小鼠样本上浓度为18 ug/ml (图 7). Sci Rep (2016) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5
赛默飞世尔白细胞介素-6抗体(EBioscience, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5). Mucosal Immunol (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔白细胞介素-6抗体(ThermoFisher, PM626)被用于. Cell Signal (2015) ncbi
大鼠 单克隆(MP520F3)
  • 酶联免疫吸附测定; 小鼠; 图 5a
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a). J Immunol (2015) ncbi
大鼠 单克隆(MP5-32C11)
  • 酶联免疫吸附测定; 小鼠; 图 5a
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-32C11)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a). J Immunol (2015) ncbi
大鼠 单克隆(MP5 20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5a
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a). J Immunol (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 5
  • 酶联免疫吸附测定; 小鼠
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 5) 和 被用于酶联免疫吸附测定在小鼠样本上. PLoS ONE (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Clin Invest (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Leukoc Biol (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 6
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 6). PLoS ONE (2014) ncbi
大鼠 单克隆(MP5 20F3)
  • 免疫印迹; 小鼠; 图 2
赛默飞世尔白细胞介素-6抗体(Invitrogen, clone AMC0864)被用于被用于免疫印迹在小鼠样本上 (图 2). BMC Cancer (2013) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 1). PLoS Pathog (2013) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 2 ug/ml
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上浓度为2 ug/ml. PLoS ONE (2011) ncbi
大鼠 单克隆(MP5 20F3)
  • 免疫组化; 小鼠; 图 4
赛默飞世尔白细胞介素-6抗体(Biosource, AMC0864)被用于被用于免疫组化在小鼠样本上 (图 4). Mol Vis (2010) ncbi
大鼠 单克隆(MP5 20F3)
  • 免疫组化; 小鼠; 图 2
赛默飞世尔白细胞介素-6抗体(Invitrogen, AMC0864)被用于被用于免疫组化在小鼠样本上 (图 2). Mol Vis (2010) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 7b
赛默飞世尔白细胞介素-6抗体(eBioscience, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 7b). J Immunol (2010) ncbi
大鼠 单克隆(MP5 20F3)
  • 其他; 小鼠; 图 6
  • 抑制或激活实验; 小鼠; 图 4
赛默飞世尔白细胞介素-6抗体(Biosource, AMC0862)被用于被用于其他在小鼠样本上 (图 6) 和 被用于抑制或激活实验在小鼠样本上 (图 4). Kidney Int (2007) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 4A
赛默飞世尔白细胞介素-6抗体(eBiosciences, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 4A). J Leukoc Biol (2007) ncbi
大鼠 单克隆(MP5 20F3)
  • 抑制或激活实验; 小鼠; 1.25 ug/ml
赛默飞世尔白细胞介素-6抗体(Biosource, MP5-20F3)被用于被用于抑制或激活实验在小鼠样本上浓度为1.25 ug/ml. Int Immunol (1999) ncbi
BioLegend
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 3d
BioLegend白细胞介素-6抗体(BioLegend, 504503)被用于被用于流式细胞仪在小鼠样本上 (图 3d). J Exp Med (2020) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 7c
BioLegend白细胞介素-6抗体(Biolegend, 504504)被用于被用于流式细胞仪在小鼠样本上 (图 7c). Cell (2019) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 表 s1
BioLegend白细胞介素-6抗体(BioLegend, 504508)被用于被用于流式细胞仪在小鼠样本上 (表 s1). J Clin Invest (2017) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 4c
BioLegend白细胞介素-6抗体(BioLegend, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 4c). J Clin Invest (2017) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 1:100; 图 7A
BioLegend白细胞介素-6抗体(Biolegend, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 7A). Nat Commun (2017) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 图 5
BioLegend白细胞介素-6抗体(Biolegend, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上 (图 5). Aging (Albany NY) (2016) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5
BioLegend白细胞介素-6抗体(Biolegend, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5). PLoS ONE (2015) ncbi
大鼠 单克隆(MP5-32C11)
  • 酶联免疫吸附测定; 小鼠; 图 5
BioLegend白细胞介素-6抗体(Biolegend, MP5-32C11)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5). PLoS ONE (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠
BioLegend白细胞介素-6抗体(Biolegend, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上. Microbes Infect (2015) ncbi
大鼠 单克隆(MP5-20F3)
  • 抑制或激活实验; 小鼠; 50 ug/mice
BioLegend白细胞介素-6抗体(BioLegend, MP5-20F3)被用于被用于抑制或激活实验在小鼠样本上浓度为50 ug/mice. Nat Commun (2014) ncbi
大鼠 单克隆(MP5-20F3)
BioLegend白细胞介素-6抗体(BioLegend, MP5-20F3)被用于. Nat Commun (2014) ncbi
安迪生物R&D
大鼠 单克隆(MP5-20F3)
  • 免疫印迹; 小鼠; 图 5d
安迪生物R&D白细胞介素-6抗体(R&D, MAB406)被用于被用于免疫印迹在小鼠样本上 (图 5d). PLoS Biol (2020) ncbi
domestic goat 多克隆
  • 抑制或激活实验; 小鼠; 2 ug/ml; 图 1f
安迪生物R&D白细胞介素-6抗体(R&D Systems, AF-406-NA)被用于被用于抑制或激活实验在小鼠样本上浓度为2 ug/ml (图 1f). Oxid Med Cell Longev (2019) ncbi
domestic goat 多克隆
  • 免疫组化; 小鼠; 1:100; 图 6a
安迪生物R&D白细胞介素-6抗体(R&D system, AF406NA)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 6a). J Am Heart Assoc (2016) ncbi
domestic goat 多克隆
  • 免疫组化; 小鼠; 1:100; 图 4
安迪生物R&D白细胞介素-6抗体(R&D systems, AF-406-NA)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 4). J Neuroinflammation (2016) ncbi
domestic goat 多克隆
  • 免疫组化-石蜡切片; 小鼠; 4 ug/ml; 图 5
安迪生物R&D白细胞介素-6抗体(R&D Systems, AF-406-NA)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为4 ug/ml (图 5). Lab Invest (2016) ncbi
domestic goat 多克隆
  • 抑制或激活实验; 小鼠; 图 6
安迪生物R&D白细胞介素-6抗体(R&D, AF-406-NA)被用于被用于抑制或激活实验在小鼠样本上 (图 6). Sci Rep (2016) ncbi
Bio X Cell
大鼠 单克隆(MP5-20F3)
  • 抑制或激活实验; 小鼠; 图 2b
Bio X Cell白细胞介素-6抗体(BioXCell, MP5-20F3)被用于被用于抑制或激活实验在小鼠样本上 (图 2b). Nat Commun (2015) ncbi
Novus Biologicals
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 4a
Novus Biologicals白细胞介素-6抗体(Novus, NB600-1131)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 4a). Cell Death Dis (2018) ncbi
亚诺法生技股份有限公司
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 6
亚诺法生技股份有限公司白细胞介素-6抗体(Abnova, PAB16165)被用于被用于免疫组化在小鼠样本上 (图 6). Int J Mol Med (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D5W4V)
  • 免疫印迹; 小鼠; 图 e5e
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell Signaling Technology, 12912)被用于被用于免疫印迹在小鼠样本上 (图 e5e). Nature (2020) ncbi
domestic rabbit 单克隆(D5W4V)
  • 免疫印迹; 小鼠; 图 2a, 2e
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell Signaling, 12912)被用于被用于免疫印迹在小鼠样本上 (图 2a, 2e). J Am Heart Assoc (2019) ncbi
domestic rabbit 单克隆(D5W4V)
  • 免疫组化-自由浮动切片; 小鼠; 1:100; 图 s20
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell Signaling, 12912)被用于被用于免疫组化-自由浮动切片在小鼠样本上浓度为1:100 (图 s20). Nat Neurosci (2019) ncbi
domestic rabbit 单克隆(D5W4V)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 6c
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell Signaling, 12912S)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 6c). Int J Biol Macromol (2018) ncbi
domestic rabbit 单克隆(D5W4V)
  • 免疫印迹; 小鼠; 图 3d
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell signaling, 12912)被用于被用于免疫印迹在小鼠样本上 (图 3d). Skelet Muscle (2017) ncbi
domestic rabbit 单克隆(D5W4V)
  • 抑制或激活实验; 人类; 图 4c
  • 免疫组化-石蜡切片; 人类; 图 5c
赛信通(上海)生物试剂有限公司白细胞介素-6抗体(Cell Signaling, 12912)被用于被用于抑制或激活实验在人类样本上 (图 4c) 和 被用于免疫组化-石蜡切片在人类样本上 (图 5c). Cell Signal (2016) ncbi
BioVision
  • 其他; 小鼠; 1:1000; 图 s1
BioVision白细胞介素-6抗体(BioVision, 5143-100)被用于被用于其他在小鼠样本上浓度为1:1000 (图 s1). Front Microbiol (2015) ncbi
碧迪BD
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 1b, 2c, 3e
碧迪BD白细胞介素-6抗体(BD Pharmingen, MP5-20F3)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 1b, 2c, 3e). Front Neurol (2020) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 1 ug/ml; 图 1e
碧迪BD白细胞介素-6抗体(BD Biosciences, 554400)被用于被用于酶联免疫吸附测定在小鼠样本上浓度为1 ug/ml (图 1e). elife (2019) ncbi
大鼠 单克隆(MP5-32C11)
  • 酶联免疫吸附测定; 小鼠; 图 1e
碧迪BD白细胞介素-6抗体(BD Biosciences, 554402)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 1e). elife (2019) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5
碧迪BD白细胞介素-6抗体(BD Pharmingen, 554400)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5). Sci Rep (2017) ncbi
大鼠 单克隆(MP5-32C11)
  • 酶联免疫吸附测定; 小鼠; 图 5a
碧迪BD白细胞介素-6抗体(BD Biosciences, 554402)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a). Oncol Rep (2017) ncbi
大鼠 单克隆(MP5-20F3)
  • 酶联免疫吸附测定; 小鼠; 图 5a
碧迪BD白细胞介素-6抗体(BD Biosciences, 554400)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a). Oncol Rep (2017) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 牛
碧迪BD白细胞介素-6抗体(BD Pharmingen, 554401)被用于被用于流式细胞仪在牛样本上. Cell Tissue Res (2016) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠; 1:50
碧迪BD白细胞介素-6抗体(BD Biosciences, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上浓度为1:50. Nat Commun (2014) ncbi
大鼠 单克隆(MP5-20F3)
  • 流式细胞仪; 小鼠
碧迪BD白细胞介素-6抗体(BD Biosciences, MP5-20F3)被用于被用于流式细胞仪在小鼠样本上. Mucosal Immunol (2014) ncbi
文章列表
  1. Xiong L, Zhao K, Cao Y, Guo H, Pan J, Yang X, et al. Linking skeletal muscle aging with osteoporosis by lamin A/C deficiency. PLoS Biol. 2020;18:e3000731 pubmed 出版商
  2. Lu Z, Zou J, Li S, Topper M, Tao Y, Zhang H, et al. Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020;579:284-290 pubmed 出版商
  3. Lee P, Selhorst A, Lampe S, Liu Y, Yang Y, Lovett Racke A. Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity. Front Neurol. 2020;11:19 pubmed 出版商
  4. Zhang C, Xie Y, Chen H, Lv L, Yao J, Zhang M, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020;12:1272-1284 pubmed 出版商
  5. Han C, Liu Y, Sui Y, Chen N, Du T, Jiang Y, et al. Integrated transcriptome expression profiling reveals a novel lncRNA associated with L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Aging (Albany NY). 2020;12:718-739 pubmed 出版商
  6. Sarker M, Lee J, Lee D, Chun K, Jun H. Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1. Aging (Albany NY). 2020;12:593-610 pubmed 出版商
  7. Kiss B, Szántó M, Hegedus C, Antal D, Szödényi A, Márton J, et al. Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis. Exp Dermatol. 2020;29:79-85 pubmed 出版商
  8. Thirugnanam K, Cossette S, Lu Q, Chowdhury S, Harmann L, Gupta A, et al. Cardiomyocyte-Specific Snrk Prevents Inflammation in the Heart. J Am Heart Assoc. 2019;8:e012792 pubmed 出版商
  9. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed 出版商
  10. Roberts A, Popov L, Mitchell G, Ching K, Licht D, Golovkine G, et al. Cas9+ conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond. elife. 2019;8: pubmed 出版商
  11. Sul O, Rajasekaran M, Park H, Suh J, Choi H. MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation. Oxid Med Cell Longev. 2019;2019:6018180 pubmed 出版商
  12. Mogilenko D, Haas J, L homme L, Fleury S, Quemener S, Levavasseur M, et al. Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR. Cell. 2019;177:1201-1216.e19 pubmed 出版商
  13. Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler R, Zhang S, et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model. Nat Neurosci. 2019;22:719-728 pubmed 出版商
  14. Lai X, Deng Z, Zhu X, Chen Z. Apc gene suppresses intracranial aneurysm formation and rupture through inhibiting the NF-κB signaling pathway mediated inflammatory response. Biosci Rep. 2019;39: pubmed 出版商
  15. Zhang G, Liu Y, Xu L, Sha C, Zhang H, Xu W. Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model. BMC Biotechnol. 2019;19:10 pubmed 出版商
  16. Gorth D, Shapiro I, Risbud M. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10:7 pubmed 出版商
  17. Kang L, Kwon E, Lee K, Cho C, Lee J, Ryu Y, et al. 3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. Br J Pharmacol. 2018;175:4295-4309 pubmed 出版商
  18. Xu Y, Xu J, Ge K, Tian Q, Zhao P, Guo Y. Anti-inflammatory effect of low molecular weight fucoidan from Saccharina japonica on atherosclerosis in apoE-knockout mice. Int J Biol Macromol. 2018;118:365-374 pubmed 出版商
  19. Song J, Zhang X, Ge Q, Yuan C, Chu L, Liang H, et al. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells. J Cell Biochem. 2018;119:8419-8431 pubmed 出版商
  20. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed 出版商
  21. Uzan J, Laas E, Alsamad I, Skalli D, Mansouri D, Haddad B, et al. Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer. Int J Mol Sci. 2017;18: pubmed 出版商
  22. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed 出版商
  23. Stacey M, Clare S, Clement M, Marsden M, Abdul Karim J, Kane L, et al. The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J Clin Invest. 2017;127:1463-1474 pubmed 出版商
  24. Perez Ruiz de Garibay A, Spinato C, Klippstein R, Bourgognon M, Martincic M, Pach E, et al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci Rep. 2017;7:42605 pubmed 出版商
  25. Loomis Z, Eigenberger P, Redinius K, Lisk C, Karoor V, Nozik Grayck E, et al. Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation. PLoS ONE. 2017;12:e0171219 pubmed 出版商
  26. Li C, Bi Y, Li Y, Yang H, Yu Q, Wang J, et al. Dendritic cell MST1 inhibits Th17 differentiation. Nat Commun. 2017;8:14275 pubmed 出版商
  27. Gopinath S. Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor. Skelet Muscle. 2017;7:2 pubmed 出版商
  28. Okuyama H, Tominaga A, Fukuoka S, Taguchi T, Kusumoto Y, Ono S. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-?. Oncol Rep. 2017;37:684-694 pubmed 出版商
  29. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed 出版商
  30. Chao M, Guo J, Cheng W, Zhu X, She Z, Huang Z, et al. Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. J Am Heart Assoc. 2016;5: pubmed 出版商
  31. Khalaj K, Luna R, de França M, de Oliveira W, Peixoto C, Tayade C. RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss. Oncotarget. 2016;7:72486-72502 pubmed 出版商
  32. Shi K, Qian J, Qi L, Mao D, Chen Y, Zhu Y, et al. Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-?B activation in HCAECs. Oncol Lett. 2016;12:1438-1444 pubmed
  33. Drake L, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016;197:1335-42 pubmed 出版商
  34. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed 出版商
  35. Zheng X, Xu M, Yao B, Wang C, Jia Y, Liu Q. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment. Cell Signal. 2016;28:1314-24 pubmed 出版商
  36. Shutinoski B, Alturki N, Rijal D, Bertin J, Gough P, Schlossmacher M, et al. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo. Cell Death Differ. 2016;23:1628-37 pubmed 出版商
  37. Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao X, et al. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 2016;12:1129-52 pubmed 出版商
  38. Holditch S, Schreiber C, Burnett J, Ikeda Y. Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females. Sci Rep. 2016;6:25623 pubmed 出版商
  39. Lee K, Lee H, Lin H, Tsay H, Tsai F, Shyue S, et al. Role of transient receptor potential ankyrin 1 channels in Alzheimer's disease. J Neuroinflammation. 2016;13:92 pubmed 出版商
  40. Seo J, Bang M, Kim G, Cho S, Park D. Erythronium japonicum attenuates histopathological lung abnormalities in a mouse model of ovalbumin-induced asthma. Int J Mol Med. 2016;37:1221-8 pubmed 出版商
  41. Ganesan S, Reynolds C, Hollinger K, Pearce S, Gabler N, Baumgard L, et al. Twelve hours of heat stress induces inflammatory signaling in porcine skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2016;310:R1288-96 pubmed 出版商
  42. Mishra V, DiAngelo S, Silveyra P. Sex-specific IL-6-associated signaling activation in ozone-induced lung inflammation. Biol Sex Differ. 2016;7:16 pubmed 出版商
  43. Mertz K, Mager L, Wasmer M, Thiesler T, Koelzer V, Ruzzante G, et al. The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology. 2016;5:e1062966 pubmed
  44. Liu Z, Gan L, Chen Y, Luo D, Zhang Z, Cao W, et al. Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes. Sci Rep. 2016;6:21382 pubmed 出版商
  45. Zhao J, Wang L, Dong X, Hu X, Zhou L, Liu Q, et al. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis. Sci Rep. 2016;6:19670 pubmed 出版商
  46. Crompton R, Williams H, Ansell D, Campbell L, Holden K, Cruickshank S, et al. Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair. Lab Invest. 2016;96:439-49 pubmed 出版商
  47. Liu C, Rajapakse A, Riedo E, Fellay B, Bernhard M, Montani J, et al. Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation. Sci Rep. 2016;6:20405 pubmed 出版商
  48. Yeh C, Slavin S, Da J, Hsu I, Luo J, Xiao G, et al. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment. Mol Cancer. 2016;15:7 pubmed 出版商
  49. Zhao C, Zhang W, Zhao Y, Yang Y, Luo H, Ji G, et al. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Sci Rep. 2016;6:19404 pubmed 出版商
  50. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  51. Piraino F, Volpetti F, Watson C, Maerkl S. A Digital-Analog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples. ACS Nano. 2016;10:1699-710 pubmed 出版商
  52. Fraveto A, Cardinale V, Bragazzi M, Giuliante F, De Rose A, Grazi G, et al. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS ONE. 2015;10:e0142124 pubmed 出版商
  53. Lee J, Park K, Han D, Bang N, Kim D, Na H, et al. PharmDB-K: Integrated Bio-Pharmacological Network Database for Traditional Korean Medicine. PLoS ONE. 2015;10:e0142624 pubmed 出版商
  54. Manda K, Tripathi P, Hsi A, Ning J, Ruzinova M, Liapis H, et al. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Oncogene. 2016;35:3282-92 pubmed 出版商
  55. Wardill H, Logan R, Bowen J, Van Sebille Y, Gibson R. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer. 2016;24:1779-88 pubmed 出版商
  56. Oliver R, Lovric V, Yu Y, Christou C, Aiken S, Cooper J, et al. Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue. PLoS ONE. 2015;10:e0136514 pubmed 出版商
  57. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed 出版商
  58. Chiang C, Uzoma I, Lane D, MemiÅ¡ević V, Alem F, Yao K, et al. A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection. Front Microbiol. 2015;6:683 pubmed 出版商
  59. Ampem G, Azegrouz H, Bacsadi Ã, Balogh L, Schmidt S, Thuróczy J, et al. Adipose tissue macrophages in non-rodent mammals: a comparative study. Cell Tissue Res. 2016;363:461-78 pubmed 出版商
  60. Somanna N, Yariswamy M, Garagliano J, Siebenlist U, Mummidi S, Valente A, et al. Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell Signal. 2015;27:1928-38 pubmed 出版商
  61. Raynor J, Karns R, Almanan M, Li K, Divanovic S, Chougnet C, et al. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age. J Immunol. 2015;195:944-52 pubmed 出版商
  62. Madaboosi N, Soares R, Chu V, Conde J. A microfluidic immunoassay platform for the detection of free prostate specific antigen: a systematic and quantitative approach. Analyst. 2015;140:4423-33 pubmed 出版商
  63. Dell Ovo V, Rosenzweig J, Burd I, Merabova N, Darbinian N, Goetzl L. An animal model for chorioamnionitis at term. Am J Obstet Gynecol. 2015;213:387.e1-10 pubmed 出版商
  64. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed 出版商
  65. Tsukamoto H, Senju S, Matsumura K, Swain S, Nishimura Y. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Nat Commun. 2015;6:6702 pubmed 出版商
  66. Rao C, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, et al. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Mol Carcinog. 2016;55:600-10 pubmed 出版商
  67. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed 出版商
  68. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed 出版商
  69. Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, et al. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma. Gynecol Oncol. 2015;136:112-20 pubmed 出版商
  70. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed 出版商
  71. Chuang H, Sheu W, Lin Y, Tsai C, Yang C, Cheng Y, et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun. 2014;5:4602 pubmed 出版商
  72. Kuwahara M, Suzuki J, Tofukuji S, Yamada T, Kanoh M, Matsumoto A, et al. The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun. 2014;5:3555 pubmed 出版商
  73. Samuelson E, Laird R, Papillion A, Tatum A, Princiotta M, Hayes S. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice. PLoS ONE. 2014;9:e92054 pubmed 出版商
  74. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed 出版商
  75. Jang J, Lee J, Jeon Y, Kim C. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer. 2013;13:421 pubmed 出版商
  76. Lu M, Varley A, Munford R. Persistently active microbial molecules prolong innate immune tolerance in vivo. PLoS Pathog. 2013;9:e1003339 pubmed 出版商
  77. Hemmers S, Teijaro J, Arandjelovic S, Mowen K. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE. 2011;6:e22043 pubmed 出版商
  78. Dvoriantchikova G, Barakat D, Hernandez E, Shestopalov V, Ivanov D. Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury. Mol Vis. 2010;16:2882-90 pubmed
  79. Dvoriantchikova G, Barakat D, Hernandez E, Shestopalov V, Ivanov D. Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury. Mol Vis. 2010;16:1907-12 pubmed
  80. Nijnik A, Madera L, Ma S, Waldbrook M, Elliott M, Easton D, et al. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol. 2010;184:2539-50 pubmed 出版商
  81. Tracz M, Juncos J, Croatt A, Ackerman A, Grande J, Knutson K, et al. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int. 2007;72:1073-80 pubmed
  82. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  83. Martín Orozco E, Kobayashi H, Van Uden J, Nguyen M, Kornbluth R, Raz E. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol. 1999;11:1111-8 pubmed